DSM inks antibody contract manufacturing deal for XD
DSM has signed an antibody contract manufacturing deal focused in its intensified cell culture process, XD.
Archives for June 18, 2012
HHS investing $400m to speed pandemic vaccine production
HHS is investing $400m (€318m) to create centres to speed development and production of medical countermeasures.